Lab Members

David J. Robbins, Ph.D.

Principal Investigator

Dr. David Robbins is a Professor of Oncology at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center. His research is focused on elucidating the roles Sonic hedgehog (Shh) and Wnt developmental signaling pathways play in cancer. For over 20 years, Dr. Robbins has been an independent investigator and has published over 100 manuscripts on multiple aspects of cancer-related pathways. He obtained a Ph.D. in Pharmacology from UT Southwestern and did his postdoctoral training at UCSF in the field of Cancer Biology.

Professor of Oncology.
BS in Biochemistry, Rutgers University, New Brunswick, NJ, USA.
Ph.D. in Cell Regulation, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Postdoctoral fellow in Cancer Biology, University of California San Francisco, San Francisco, CA, USA.
Faculty since 1998.
Ongoing NIH funding: R01CA244188 (MPI).
Dr. Robbins is a founder and a Director of Stemsynergy Therapeutics, a company focused on the development of Wnt, Notch and SHH inhibitors.

Current Lab Members

Daniel Wynn, Ph.D.

Assistant Professor

Assistant Professor (02/2025-present)

Postdoctoral fellow (08/2018-01/2025)

Email: dw927@georgetown.edu

Said Afify, Ph.D.

Assistant Scientist

Assistant Scientist (07/2023- present)

Postdoctoral fellow (04/2022-07/2023)

Email: sa1901@georgetown.edu

Afify completed his PhD in Cancer Biology from Okayama University, Japan. He moved to the Department of Oncology at the Lombardi Comprehensive Cancer Center in 2022. The main focus of his research is modeling the metastasis of colorectal cancer.